Cecilia Hultén

Swedish, born 1968. Cecilia Hultén is a distinguished business leader with a career spanning over two decades in the financial industry. Her experience includes executive roles at major institutions such as UBS and Nordea, where she developed strong financial acumen and expertise in building international businesses within capital markets. Cecilia has transitioned from a global banking executive to a prominent entrepreneur, investor and board member. Her focus has shifted to transformative businesses addressing real-world challenges. Cecilia’s venture portfolio holds investments in the fintech, tech, and health tech sectors. Of her portfolio companies, she is on the Board of kompasbank, a pan-European neo-bank for SMEs, and Cbio A/S. In 2023, she successfully exited her investment in Hejdoktor, a digital healthcare provider, following its acquisition by a strategic investor. She has co-founded two companies: a biotech company in 2019, Cbio A/S, a next-generation T-Cell therapy company now a clinical-stage company, and a data management company commercializing a project from MIT’s fintech program, where she has taken the role of CFO. Cecilia holds a BSc from the Gothenburg School of Economics and studied on the Stern School of Business MBA program at NYU. Additionally, Cecilia spent five years as an executive coach at Stanford Graduate School of Business in Corporate Innovation in its LEAD program, where she graduated. Acknowledging the importance of Sustainability matters, Cecilia is also acting as the Board executive sponsor for Sustainability and ESG matters and is the Chair of the Nomination, Compensation & Sustainability Committee.